A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
/in Breast Cancer, Colorectal Cancer, Dendritic Cells, International Publications, Ovarian Cancer, Pancreatic CancerUse of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma
/in Glioblastoma, International Publications, Newcastle Disease VirusCutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
/in Hyperthermia, International PublicationsFor the clinical application of thermochemotherapy given at mild temperatures
/in Hyperthermia, International PublicationsCellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
/in Dendritic Cells, Hypernephroma, International PublicationsTumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures
/in International Publications, Newcastle Disease Virus[Hyperthermia in combination with chemotherapy in gynecological cancers]
/in Hyperthermia, International PublicationsA pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
/in Hyperthermia, International PublicationsHuman tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
/in International Publications, Newcastle Disease VirusIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer